- Home
- SLAB vs AXSM Comparison
SLAB vs AXSM Comparison
Compare SLAB & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLAB | AXSM |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 7.3B |
| IPO Year | 2000 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SLAB | AXSM |
|---|---|---|
| Price | $221.43 | $130.44 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 22 |
| Target Price | $222.86 | ★ $271.05 |
| AVG Volume (30 Days) | 272.3K | ★ 1.0M |
| Earning Date | 11-17-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.61 | 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $491,625,000.00 | N/A |
| Revenue This Year | $18.15 | $49.41 |
| Revenue Next Year | $16.47 | $52.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $115.51 | $123.00 |
| 52 Week High | $223.14 | $260.19 |
Technical Indicators
Market Signals| Indicator | SLAB | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 54.92 | 24.59 |
| Support Level | $216.61 | N/A |
| Resistance Level | $222.66 | $225.16 |
| Average True Range (ATR) | 0.80 | 7.04 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 62.07 | 33.50 |
Price Performance
Historical ComparisonAbout SLAB Silicon Laboratories Inc.
Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.